Results 231 to 240 of about 872,427 (309)

The features and risk factors of thrombotic thrombocytopenic purpura in systemic lupus erythematosus. [PDF]

Orphanet J Rare Dis
Ma H, He Y, Li S, Yang Y, Huo L, Li T.
europepmc   +1 more source

Congenital complete heart block in the newborn associated with maternal systemic lupus erythematosus and other connective tissue disorders.

, 1979
Judy Hardy, Scott D. Solomon, G. S. Banwell, R. K. Beach, Victor J. Wright, F M Howard   +5 more
openalex   +1 more source

Systemic Lupus Erythematosus [PDF]

Canadian Psychiatric Association Journal, 1972
openaire   +2 more sources

GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane‐induced lupus mouse model

British Journal of Pharmacology, EarlyView.
Background and Purpose Systemic lupus erythematosus is an autoimmune, multisystemic disease affecting all organs in the body. Accrued evidence has elucidated a role for autophagy in the onset and severity of systemic lupus erythematosus. The antimalarial drug hydroxychloroquine constitutes the cornerstone of standard of care for systemic lupus ...
Eya Toumi, Eloïne Bestion, Muriel Militello, Hubert Lepidi, Anne Plauzolles, Nathalie Bardin, Daniel Bertin, Laurent Chiche, Jean‐Louis Mege, Philippe Halfon, Soraya Mezouar   +10 more
wiley   +1 more source

A Case of Systemic Lupus Erythematosus Complicated by Secondary Evans Syndrome. [PDF]

Cureus
Drallmeier M, Grossmann M, Haftka-George A.   +2 more
europepmc   +1 more source

Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis

British Journal of Pharmacology, EarlyView.
Abstract Autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) result from immune self‐tolerance loss, causing tissue damage. Standard treatments targeting late‐stage inflammation often have serious side effects. Artemisinin, known for its antimalarial properties, shows potential immunomodulatory effects.
Fanchao Zhou, Guoming Li, Ruixiang Tan, Guodong Wu, Changsheng Deng   +4 more
wiley   +1 more source

Genetic and epigenetic factors shape phenotypes and outcomes in systemic lupus erythematosus - focus on juvenile-onset systemic lupus erythematosus. [PDF]

Curr Opin Rheumatol
Charras A, Hiraki LT, Lewandowski L, Hedrich CM.   +3 more
europepmc   +1 more source

Diffuse ischemic colitis associated with systemic lupus erythematosus-response to subtotal colectomy

, 1978
Martin Kistin, Marshall M. Kaplan, John T. Harrington   +2 more
openalex   +1 more source

Genetic Profiling Reveals the Distinctions Among MTX‐Associated DLBCL, EBV‐Positive Mucocutaneous Ulcer, and EBV + DLBCL

Cancer Science, EarlyView.
EBV‐ MTX‐DLBCL shows higher driver gene mutation rates and worse outcomes after MTX discontinuation compared to EBV+ MTX‐DLBCL. IDD‐LPDs have lower mutation rates in genes related to clonal hematopoiesis (TET2/DNMT3A) and immune evasion (CD58) compared to EBV + DLBCL. ABSTRACT The WHO recently changed the outline of immunodeficiency/dysregulation (IDD)‐
Takumi Takahashi, Keisuke Sawada, Takahisa Yamashita, Wataru Yamamoto, Yosuke Iijima, Akiko Adachi, Makoto Kashimura, Takayuki Tabayashi, Masahiro Kizaki, Takahiro Kaneko, Jun‐ichi Tamaru, Morihiro Higashi, Shuji Momose   +12 more
wiley   +1 more source